Dr. Brian Durie: "ICER Blinks and Patients Benefit"

IMF Chairman Dr. Brian Durie calls the much-awaited Final Report from the Institute for Clinical and Economic Review (ICER) “less of a report than an admission that they do not have the expertise to adequately assess the complexities of new myeloma therapies.” In his blog this week, Dr. Durie notes that the report defers to the expertise of both doctors and patient advocates, and, importantly, that the International Myeloma Working Group has already launched an inclusive project to create treatment guidelines that can transform the cost/payer landscape.
Source: International Myeloma Foundation - Category: Hematology Source Type: news
More News: Blogging | Hematology | Myeloma